At the molecular level, breast cancer cells and associated stromal elements contribute to a hypercoagulable state through increased expression of tissue factor (TF), release of pro-inflammatory cytokines, and production of TF-bearing extracellular vesicles. The gene discussed is TF; the disease is breast carcinoma.